IBA H1 sales up 38 pct, just above forecasts
BRUSSELS, Aug 29 (Reuters) - Belgian cancer diagnosis and therapy company Ion Beam Applications (IBAB.BR: Quote, Profile, Research, Stock Buzz) reported a 37.7 percent rise in first-half revenues on Friday, slightly above analyst expectations.
Revenues in the first six months increased to 133.1 million euros ($196.2 million) from 96.7 million euros a year earlier. Analysts had been expecting a figure of 131 million euros.
Recurring EBIT (earnings before interest and tax) fell 3.9 percent to 5.36 million euros, while net profit fell 32.4 percent to 4.83 million euros against expectations of 8.2 million and 8.4 million euros respectively.
© Thomson Reuters 2008 All rights reserved
Ads by Career Builder
Revenue Cycle Management/ Healthcare
Details: Growing Healthcare Consultancy organization...seeks experienced Healthcare Revenue Cycle Management...initiatives to healthcare providers and payers...
Work from Home as a Healthcare Recruiter
Details: ...from Home as a Healthcare Recruiter Health...an international healthcare recruiting and...represents high-demand healthcare professionals and...
Regional Operations Director - Healthcare
Details: ...Operations Director - Healthcare This position will...skills/experience: Healthcare Multi-Site Management...benefits including the healthcare industry's most...
Lawson Analyst - Payroll for healthcare
Details: ...experience within a healthcare industry environment...Application Analyst, Healthcare Systems, Payroll...Analyst - Payroll for healthcare position, and have...
Attacks fuel India-Pakistan tensions
